MBDA press release
Soon to start equipping the Royal Navy’s AW159 Wildcat and Marine nationale’s H160M Guépard shipborne helicopters, the Sea Venom/ANL anti-ship missile is a co-operation project developed under the Lancaster House treaty between France and the United Kingdom. The Sea Venom/ANL missile is the first programme to take full advantage of the cross-border centres of excellence on missile technologies launched by the Lancaster House treaty, which celebrated its 10-year anniversary this month.
The final qualification trial tested the missile’s advanced target discrimination within a complex and cluttered naval scenario.
“I want to congratulate the UK-French teams across both MBDA and our governments for the commitment they have shown in meeting this qualification milestone amid the disruption caused by Covid-19. Together they have proven that through co-operation we can jointly overcome adversity and deliver leading edge military capabilities.”
Éric Béranger, MBDA CEO
Previous trials have tested the missiles launch envelope, release envelope and engagement modes, such as its low-altitude sea-skimming flight, lock on after launch (LOAL), lock on before launch (LOBL), operator-in-the-loop, and aimpoint refinement.
